Dissection of 4L lymph node for left-sided non-small cell lung cancer: a meta-analysis.

Han-Yu DengDeyan LiXiao-Ming QiuDa-Xing ZhuXiaojun TangQinghua Zhou

Published in: ANZ journal of surgery (2021)

Dissection of 4L lymph node could significantly improve both 5-year OS and DFS rates and 4L LND was a favorable prognostic factor for patients with left-sided NSCLC.

Keyphrases

lymph node
prognostic factors
sentinel lymph node
neoadjuvant chemotherapy
small cell lung cancer
advanced non small cell lung cancer
squamous cell carcinoma
tyrosine kinase